Furthering its mission of launching innovative research and educational activities that drive improved outcomes for women with cardiovascular disease, the SCAI Women in Innovations (“WIN”) initiative is undertaking two projects that will use the National Cardiovascular Data Registry (NCDR) to help uncover new information about why women often experience worse outcomes than men when undergoing similar cardiovascular procedures.
“The NCDR is a fabulous and often underutilized resource,” explained SCAI WIN Program Chair Roxana Mehran, M.D., FSCAI. “We are hoping to tap into the registry to further WIN’s primary goal of understanding why there are sex-based discrepancies in procedural outcomes, and how they can be prevented.”
The first NCDR-based project SCAI WIN will undertake builds on the utility of the CATH PCI Registry in assessing practice gaps and potential areas for improvement. SCAI WIN will submit two queries to CATH PCI for consideration. One will look at translating research into practice to determine if adoption rates of new clinical information differ for male versus female PCI patients, while a second query will compare PCI practice patterns between female and male interventional cardiologists.
“The idea behind both of these questions is to increase transparency,” said Tracy Wang, M.D., MHS, MS, who is the lead investigator for SCAI WIN’s CATH PCI studies. “Patient care doesn’t improve without asking the tough questions. The goal is to find novel data that will be of high impact to the field, and of course aligned with the WIN mission of addressing disparities in cardiovascular care and professionalism.”
The second project SCAI WIN will roll out with NCDR is inclusion of the database in discussion around how retrospective registries might inform prospective clinical studies. During the second SCAI WIN / ACC Gender Data Forum, NCDR staff will present examples of how to use the registry to answer questions which might decide how prospective clinical studies could be better designed. The insights from NCDR staff are expected to further the Data Forum’s overall goal of using existing data sources to improve clinical studies as they relate to women.
“There is a great deal we can learn from the NCDR,” noted Dr. Mehran. “The advantage in having NCDR present at the Data Forum is that several major trial investigators as well as representatives from the sponsoring companies for those trials will be on site, giving us a first-hand opportunity to pinpoint areas for improvement and integrate that information into strategies for upcoming clinical trials. It’s an exciting prospect.”
To learn more about SCAI Women in Innovations, visit www.scai-win.org.